Benjamin Edwards’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $39.2M | Buy |
149,540
+1,076
| +0.7% | +$284K | 0.35% | 70 |
|
|
2026
Q2 | $32.8M | Sell |
148,464
-15,570
| -9% | -$4.31M | 0.3% | 96 |
|
|
2026
Q1 | $48.5M | Buy |
164,034
+36,318
| +28% | +$10.8M | 0.48% | 48 |
|
|
2025
Q4 | $34.9M | Buy |
127,716
+125,519
| +5,713% | +$34.1M | 0.39% | 73 |
|
|
2025
Q3 | $594K | Buy |
2,197
+539
| +33% | +$147K | 0.01% | 878 |
|
|
2025
Q2 | $457K | Buy |
1,658
+186
| +13% | +$50.6K | 0.01% | 874 |
|
|
2025
Q1 | $391K | Sell |
1,472
-37
| -2% | -$9.13K | 0.01% | 865 |
|
|
2024
Q4 | $351K | Buy |
1,509
+22
| +1% | +$5.06K | 0.01% | 940 |
|
|
2024
Q3 | $328K | Sell |
1,487
-651
| -30% | -$135K | ﹤0.01% | 923 |
|
|
2024
Q2 | $420K | Buy |
2,138
+104
| +5% | +$21.5K | 0.08% | 242 |
|
|
2024
Q1 | $438K | Buy |
2,034
+770
| +61% | +$162K | 0.09% | 235 |
|
|
2023
Q4 | $266K | Sell |
1,264
-302
| -19% | -$64.4K | 0.06% | 274 |
|
|
2023
Q3 | $314K | Buy |
1,566
+84
| +6% | +$16.7K | 0.07% | 221 |
|
|
2023
Q2 | $275K | Buy |
1,482
+32
| +2% | +$5.91K | 0.06% | 235 |
|
|
2023
Q1 | $278K | Buy |
1,450
+123
| +9% | +$22.2K | 0.07% | 229 |
|
|
2022
Q4 | $223K | Buy |
1,327
+391
| +42% | +$67.9K | 0.06% | 248 |
|
|
2022
Q3 | $166K | Buy |
936
+71
| +8% | +$14K | 0.05% | 273 |
|
|
2022
Q2 | $177K | Buy |
865
+192
| +29% | +$40.7K | 0.05% | 267 |
|
|
2022
Q1 | $160K | Buy |
673
+214
| +47% | +$50.3K | 0.05% | 297 |
|
|
2021
Q4 | $105K | Buy |
459
+243
| +113% | +$53.5K | 0.03% | 340 |
|
|
2021
Q3 | $42K | Buy |
216
+210
| +3,500% | +$42.5K | 0.03% | 325 |
|
|
2021
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 401 |
|
|
2021
Q1 | $1K | Buy |
+6
| New | +$1.18K | ﹤0.01% | 369 |
|
|
2020
Q3 | – | Sell |
-87
| Closed | -$14K | – | 357 |
|
|
2020
Q2 | $14K | Sell |
87
-2,578
| -97% | -$462K | 0.01% | 274 |
|
|
2020
Q1 | $461K | Buy |
2,665
+172
| +7% | +$34.2K | 0.48% | 75 |
|
|
2019
Q4 | $500K | Buy |
2,493
+124
| +5% | +$25.4K | 1.02% | 27 |
|
|
2019
Q3 | $501K | Buy |
2,369
+205
| +9% | +$42.8K | 1.09% | 24 |
|
|
2019
Q2 | $420K | Buy |
2,164
+1,514
| +233% | +$279K | 1.02% | 25 |
|
|
2019
Q1 | $107K | Buy |
+650
| New | +$115K | 0.51% | 56 |
|
Other funds holding CME
Benjamin Edwards's CME Position: Q3 2026 in Review
Benjamin Edwards increased its CME Group (CME) stake by 0.72% in Q3 2026, buying an estimated $284K and bringing the position to 149,540 shares worth $39.2M. The position accounts for 0.35% of the portfolio, ranked #70.
Benjamin Edwards first reported a position in CME in Q1 2019 and has held it in 29 quarters since. The position peaked at $48.5M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.
- Benjamin Edwards held 149,540 shares of CME Group worth $39.2M as of Q3 2026.
- Benjamin Edwards bought 1,076 CME Group shares in Q3 2026, an estimated $284K.
- CME Group made up 0.35% of Benjamin Edwards's portfolio in Q3 2026, its #70 holding.
- Benjamin Edwards first reported a position in CME Group in Q1 2019 and has held it in 29 quarters since.
- Benjamin Edwards's CME Group position peaked at $48.5M in Q1 2026.
- 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.